```html

Bilharziasis (Schistosomiasis) – A Comprehensive Medical Guide

Overview

What it is: Bilharziasis, more commonly known as schistosomiasis, is a parasitic disease caused by flatworms (flukes) of the genus Schistosoma. The parasites mature in freshwater snails and release larval forms (cercariae) that can penetrate human skin during contact with contaminated water.

Who it affects: The disease is most prevalent in tropical and subtropical regions where safe water and sanitation are limited. Over 240 million people are infected worldwide, with the highest burden in sub‑Saharan Africa, South America, the Caribbean, the Middle East, and parts of East Asia <sup>[1][2]</sup>.

Global prevalence: According to the World Health Organization (WHO), an estimated 800 million people are at risk of infection, and each year there are roughly 200,000 deaths attributable to severe complications <sup>[2]</sup>. In the United States, cases are rare and usually occur in travelers or immigrants returning from endemic areas.

Symptoms

Symptoms can be divided into three phases: (1) cercarial dermatitis (the “swimmer’s itch”), (2) acute (Katayama) fever, and (3) chronic disease that may affect the urinary tract, intestines, liver, or bladder. Not everyone infected will have noticeable symptoms; many remain asymptomatic for years.

Early (Cercarial Dermatitis)

• Itchy rash at the site of skin penetration, usually 30 minutes to 2 days after exposure.
• Red papules or vesicles that may become a maculopapular rash.

Acute (Katayama) Syndrome – occurs 2–8 weeks after infection

• Fever, chills, and sweats
• Headache and malaise
• Muscle aches (myalgia) and joint pain
• Abdominal pain, nausea, and diarrhea (may be bloody)
• Cough and respiratory discomfort (due to migration of larvae through lungs)
• Hepatosplenomegaly (enlarged liver/spleen)
• Eosinophilia on blood test (high eosinophil count)
• Weight loss

Chronic Disease – months to years after infection

• Urinary schistosomiasis (S. haematobium):
  • Hematuria (blood in urine), often painless
  • Frequency, urgency, dysuria
  • Bladder wall thickening, fibrosis, or calcification
  • Increased risk of squamous cell carcinoma of the bladder
• Intestinal schistosomiasis (S. mansoni, S. japonicum, S. intercalatum):
  • Abdominal pain, especially in the lower quadrants
  • Diarrhea – may be bloody
  • Weight loss, growth retardation in children
  • Hepatomegaly, splenomegaly, and portal hypertension
  • Fibrosis of the intestinal wall leading to strictures or obstruction
• Hepatic/splenic disease (mainly S. mansoni, S. japonicum):
  • Ascites (fluid accumulation in abdomen)
  • Esophageal or gastric varices (dangerous bleeding risk)
  • Fatigue and anemia

Causes and Risk Factors

What causes bilharziasis?

The disease is caused by infection with one of several species of Schistosoma:

• Schistosoma haematobium – urinary tract (most common in Africa & Middle East)
• Schistosoma mansoni – intestinal and hepatic disease (East Africa, South America)
• Schistosoma japonicum – intestinal disease, more severe hepatic involvement (China, Philippines)
• Other less common species (S. intercalatum, S. mekongi, S. guineensis)

Life cycle summary:

1. Infected freshwater snails release cercariae into water.
2. Cercariae penetrate human skin during activities such as bathing, swimming, fishing, or agricultural work.
3. Parasites migrate through the bloodstream, mature, and lay eggs in blood vessels.
4. Some eggs are passed in urine or feces, reaching water and restarting the cycle.

Who is at risk?

• People living in endemic rural communities with limited access to clean water.
• Children who frequently play or swim in contaminated water.
• Agricultural workers, fishermen, and irrigation workers.
• Travelers, expatriates, or immigrants who spend time in endemic areas.
• Immunocompromised individuals may experience more severe disease.

Diagnosis

Accurate diagnosis combines clinical suspicion with laboratory and imaging tools.

Laboratory Tests

• Stool microscopy – detection of Schistosoma eggs (most useful for intestinal species). Multiple samples increase sensitivity.
• Urine microscopy – filtration method to identify S. haematobium eggs; best performed between 10 am–2 pm when egg excretion peaks.
• Serologic tests – ELISA or indirect hemagglutination for antibodies; helpful in early infection when eggs are not yet excreted, but cannot differentiate past from current infection.
• Antigen detection (CCA, CAA) – Circulating cathodic/anion antigen assays are increasingly used for rapid field diagnosis, especially for S. mansoni.
• Complete blood count – eosinophilia is a common clue but not diagnostic.

Imaging

• Ultrasound – evaluates liver, spleen, bladder wall, and detects periportal fibrosis (“pipe‑stem” fibrosis).
• CT/MRI – used for complicated cases (e.g., granulomas, organomegaly, vesical wall masses).
• Colonoscopy or sigmoidoscopy – visualizes intestinal mucosal lesions when chronic intestinal disease is suspected.

Diagnosis in Travelers

In non‑endemic countries, a detailed exposure history (freshwater contact in known endemic regions) is essential. If laboratory confirmation is not immediately available, empiric treatment may be considered when the pre‑test probability is high.

Treatment Options

Effective treatment is available, and early therapy reduces morbidity.

First‑line medication

• Praziquantel – the drug of choice for all species.
  • Dosage: 40 mg/kg in two divided doses (20 mg/kg each) for S. haematobium and S. mansoni; 60 mg/kg in three divided doses for S. japonicum.
  • Single‑course cure rates exceed 80–90 % in most studies <sup>[3]</sup>.
  • Well‑tolerated; side effects include nausea, abdominal discomfort, and transient dizziness.
• Oxamniquine – an alternative for S. mansoni where praziquantel resistance is suspected, given as a single 30 mg/kg dose.

Management of Complications

• Bladder pathology – surgical removal of large polyps, endoscopic coagulation of bleeding lesions, or, in severe cases, cystectomy.
• Hepatosplenic disease – beta‑blockers for portal hypertension, endoscopic band ligation for varices, and liver transplantation in end‑stage disease.
• Renal involvement – control of hematuria, regular imaging, and referral to urology for obstructive complications.

Adjunctive measures

• Iron supplementation for anemia.
• Nutrition counseling to address weight loss and growth retardation in children.
• Anthelmintic re‑treatment 6–12 months after the first dose in high‑transmission areas to clear newly acquired infections.

Living with Bilharziasis (schistosomiasis)

While the infection can be cured, many people live with residual organ changes. Practical self‑care strategies include:

• Regular follow‑up – repeat stool/urine exams 4–6 weeks after treatment to confirm cure.
• Monitor urinary symptoms – persistent hematuria warrants cystoscopic evaluation.
• Maintain a balanced diet – protein‑rich foods support liver regeneration.
• Hydration – adequate fluid intake helps flush the urinary tract.
• Physical activity – low‑impact exercise improves circulation without risking exposure to contaminated water.
• Psychosocial support – chronic disease can affect mental health; community groups and counseling are beneficial.

Prevention

Because the disease is linked to environmental exposure, prevention combines personal precautions with community‑level interventions.

Personal protective measures

• Avoid swimming, wading, or washing in freshwater bodies known to be endemic.
• If contact is unavoidable, wear waterproof footwear and protective clothing that covers most of the skin.
• Shower with clean water immediately after exposure to reduce cercarial penetration.
• Use well‑maintained latrines to prevent contamination of water sources with eggs.

Community‑level strategies

• Mass drug administration (MDA) – WHO recommends annual praziquantel distribution to at‑risk populations in endemic regions.
• Snail control – mollusciciding (e.g., niclosamide), environmental modification (draining stagnant pools), and introduction of natural predators.
• Safe water supply – provision of piped, treated water for drinking and hygiene.
• Health education – school‑based programs teaching children about transmission and safe water practices.

Complications

If left untreated, schistosomiasis can lead to serious, sometimes life‑threatening conditions.

• Genitourinary complications: bladder cancer (especially squamous cell carcinoma), obstructive uropathy, renal failure.
• Hepatosplenic disease: periportal fibrosis, portal hypertension, ascites, hepatic encephalopathy.
• Intestinal complications: strictures, megacolon, intestinal obstruction, malabsorption.
• Neurologic involvement: spinal cord granulomas, cerebral lesions causing seizures or focal deficits (rare, usually with S. japonicum).
• Pregnancy outcomes: increased risk of anemia, low birth weight, and pre‑term delivery.
• Immunologic effects: heightened susceptibility to other infections (e.g., HIV, hepatitis) due to immune modulation.

When to Seek Emergency Care

References

1. World Health Organization. Schistosomiasis. 2022. https://www.who.int/news-room/fact-sheets/detail/schistosomiasis
2. Mayo Clinic. Schistosomiasis (Bilharzia). 2023. https://www.mayoclinic.org/diseases-conditions/schistosomiasis/symptoms-causes/syc-20354371
3. CDC. Schistosomiasis – Treatment. 2024. https://www.cdc.gov/parasites/schistosomiasis/treatment.html
4. Cleveland Clinic. Schistosomiasis (Bilharzia). 2023. https://my.clevelandclinic.org/health/diseases/21556-schistosomiasis-bilharzia
5. National Institutes of Health. Clinical Management of Schistosomiasis. 2022. https://www.ncbi.nlm.nih.gov/books/NBK537079/

```